Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV

Author(s):
Peltenburg, N.C.; Bierau, J.; Bakker, J.A. (0000-0002-2918-7361); Schippers, J.A.; Lowe, S.H.; Paulussen, A.D.C.; Bosch, B.J.C. van den; Leers, M.P.G.; Hansen, B.E.; Verbon, A.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-01-12
Language
English
Is part of
PLoS ONE (2018), No. 1
hdl
1887/76799
doi
10.1371/journal.pone.0191069